|Last Update: 05/17/13 - 4:00 PM EDT|
|YTD Performance: 18.44%|
|Previous Close: $29.86|
|52 Week Range: $19.30 - $30.56|
|Oustanding Shares: 1,160,646,709|
|Market Cap: 34,656,910,731|
|Qtr (06/13)||Qtr (09/13)||FY (12/13)||FY (12/14)|
|Number of Analysts||12||11||14||14|
|Growth Rate (Year over Year)||0.88%||-6.64%||-11.04%||12.92%|
Shares of BK now seen reaching $29, according to Jefferies. Estimates also increased, given higher equity returns. Hold rating.
BK was downgraded from Buy to Neutral, Guggenheim said. Valuation call, based on a $28 price target.
Here are the basics -- and, all told, the risk issues here appear to be capped and stable.
Even after a strong 2012, the sector is still playing catch-up with the rest of the market.
Shares of BK now seen reaching $26, according to Bank of America/Merrill Lynch. Estimates also reduced, as the company is experiencing margin pressure. Neutral rating.
Jill Malandrino of TheStreet's Options Profits reviews what traders will be focused on for Wednesday.
BK was downgraded from Neutral to Sell, Goldman Sachs said. $22 price target. Company faces multiple earnings headwinds.
Shares of BK downgraded to Neutral from Buy, Citi said. Valuation call.
Given its recent earnings and that it's trading higher than two larger-cap peers, it seems best to avoid the stock.